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Background: In acute coronary syndrome (ACS) patients with deterioration of 
coronary flow during percutaneous coronary intervention (PCI), a scattered necrotic 
core pattern (SNC) is observed by intravascular ultrasound Virtual Histology (VH-
IVUS). The purpose of this study was to evaluate the impact of SNC on deterioration of 
coronary flow during PCI in ACS. 
Methods: A total of 38 ACS patients were imaged using VH-IVUS before PCI. In 
addition to conventional definitions of thin-cap fibroatheroma by VH-IVUS (ID-TCFA), 
the SNC was defined as necrotic core foci with a maximum diameter of <14 pixels on a 
400 × 400 VH-IVUS image in the presence of >50% plaque burden except in the ID-
TCFA frame. 
Results: Patients were divided into deterioration of coronary flow group (n = 15) and 
normal-reflow group (n = 23). The incidence of residual thrombus and plaque rupture, 
the external elastic membrane, plaque and fibrous volumes, the incidence of ID-TCFA 
and the average number of SNC per frame was significantly greater in deterioration of 
coronary flow group than in normal-reflow group (P <0.05 all parameters). Multivariate 
analysis revealed that the average number of SNC per frame was independently 
associated with deterioration of coronary flow in ACS patients (odds ratio 1.18, P 
<0.05). 
Conclusions: Increased number of SNC is associated with deterioration of coronary 
flow during PCI in ACS patients. 
 





In the era of primary intervention for acute coronary syndrome (ACS), several 
investigators have documented that the slow flow phenomenon during or after primary 
coronary intervention (PCI) results in reduced left ventricular ejection fraction, left 
ventricular remodeling, and poor clinical outcomes1. Indeed, recent intravascular 
ultrasound (IVUS) studies have shown that decreased plaque volume, as a result of 
mechanical dilation or disruption, contributes to the mechanism of embolization2. 
Therefore, accurately identifying lesion characteristics and plaque components at high 
risk of causing slow flow during an interventional procedure is of crucial importance3. 
As a qualitative assessment, previous studies have suggested that the presence of 
a lipid core, plaque rupture of vulnerable lesions and thrombus formation are all 
associated with the no-reflow phenomenon4, 5. Furthermore, pathological analysis of the 
aspirates taken at the time of the no-reflow phenomenon has detected not only thrombus 
formation, but also plaque components, including foam-shaped macrophages, 
aggregated platelets, and cholesterol crystals6. Virtual Histology (VH)-IVUS uses 
spectral analysis of the radiofrequency ultrasound backscatter signals which allows the 
identification of four different types of atherosclerotic plaque components: fibrous, 
fibrofatty, dense calcium, and necrotic core, and provides some important information 
on lesion characteristics and other plaque components7. A recent VH-IVUS study 
suggested that heterogeneity of plaque components, such as fibrous and fibrofatty rich 
plaque, was associated with no-reflow phenomenon8. VH-IVUS images of vulnerable 
plaque at culprit lesions in a saphenous vein graft showed the presence of fibrofatty9 and 
fibrofatty plaque with scattered necrotic core (SNC)10. Furthermore, we have often 
observed SNC by VH-IVUS in ACS patients with deterioration of coronary flow during 
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PCI. Accordingly, we hypothesized that the identification of SNC by VH-IVUS would 
be associated with the deterioration of coronary flow during an interventional procedure 
in patients with ACS. The aim of this study was to investigate the relationship between 
the pre-interventional lesion characteristics and incidence of deterioration of coronary 




Forty-nine consecutive patients with ACS were enrolled in the study. The 
patients had either acute myocardial infarction (AMI) within 24 hours of onset or 
unstable angina of Braunwald class IIIB (i.e. angina at rest within 48 hours, with no 
creatine kinase-MB elevation). The diagnosis of AMI was determined by the presence 
of >30 minutes of continuous chest pain, ST-segment elevation >2.0 mm on at least 2 
contiguous electrocardiogram leads, >3-fold increase in serum creatine kinase levels, 
and thrombolysis in myocardial infarction (TIMI) flow grade 0, 1, or 2 at the time of the 
initial emergency coronary angiography11. We excluded patients with a previous 
myocardial infarction of the target vessel, bypass failure, subacute thrombosis or 
restenosis after PCI, chronic total occlusion, and atrial fibrillation. Patients in whom 
adequate IVUS images could not be obtained were also excluded. A glycoprotein 
IIb/IIIa inhibitor was not used in this study, because of its nonavailability in the country 
where this study was performed (Japan). Written informed consent was obtained from 
all subjects in accordance with the guidelines of the Bioethical Committee on Medical 




PCI procedure and IVUS imaging protocol 
Coronary angiography was performed via the femoral or radial approach. All 
patients received an intravenous bolus injection of 3,000 IU of heparin and 
intracoronary isosorbide dinitrate (2 mg) before angiography. Before PCI, an additional 
5,000 IU of heparin was administered and a conventional 0.014-inch guidewire was 
advanced beyond the target lesion. If thrombi had been detected angiographically or the 
lesion presented with a total occlusion, an aspiration catheter was advanced over the 
guidewire and a thrombectomy was performed. After adjunctive thrombectomy, TIMI II 
or III coronary flow was confirmed angiographically. A 20-MHz, 3.2-F phased-array 
IVUS catheter (Eagle Eye Gold, Volcano Corp, Rancho Cordova, CA) was carefully 
advanced to a position distal to the lesion, and was then pulled back at a rate of 
0.5 mm/s from the distal to the proximal part, using an auto-motorized pullback system. 
Balloon dilatation or stent implantation was performed after IVUS examination. 
 
Angiographical analysis 
The offline quantitative coronary angiography analyses were performed by 2 
experienced observers who were unaware of the IVUS measurements using the 
automated edge detection system (Anchor, Siemens or Cardiovascular Measurement 
System, Goodman). From the quantitative coronary angiography images, the minimal 
lumen diameter, diameter stenosis and length of the stenosis were calculated. The 
corrected TIMI frame count, which is a quantitative parameter of reperfusion epicardial 
flow, after thrombectomy and immediately after mechanical dilation (e.g. balloon 
inflation, stent deployment), was estimated in the infarct-related artery as previously 
reported12. We defined deterioration of coronary flow during PCI as an increase in the 
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corrected TIMI frame count after mechanical dilation compared with corrected TIMI 
frame count after thrombectomy, and without any evidence of dissection, severe 
stenosis, and vasospasm. 
 
Grayscale and VH-IVUS data analysis 
Serial IVUS images were digitized and stored on the hard disk of the IVUS 
console (IVG3, Volcano Corp, Rancho Cordova, CA) for off-line analysis. Quantitative 
volumetric grayscale and VH-IVUS analysis were performed across the entire lesion 
segment, and cross-sectional analysis was performed at minimal lumen sites. Qualitative 
assessment and quantitative measurements were performed as previously reported13. 
The culprit lesion was defined as the site of the smallest lumen, and the reference 
segments were the most normal-looking cross-sectional area (CSA) within 5 mm 
proximal and distal to the lesion. Morphometric parameters of external elastic 
membrane (EEM) CSA and lumen CSA were measured at the lesion and the reference 
site. Plaque and media CSA were calculated as EEM CSA minus lumen CSA, and 
plaque burden was calculated as plaque and media CSA divided by EEM CSA  100. 
Remodeling index was calculated as the EEM CSA at the minimum lumen diameter 
divided by the proximal reference EEM CSA. Positive remodeling was defined as 
remodeling index >1.0. Thrombus formation was defined as a distinct hypoechoic mass, 
brightly speckled plaque, the presence of channels into the plaque, evacuated plaque 
cavity and an intraluminal mobile mass. A lipid pool-like image was defined as a 
pooling of low echogenic material that was covered by a thin, high-echogenic layer. 
Ruptured plaque was defined as plaque ulceration with a torn fibrous cap. Spotty 
calcification was defined as bright echoes in the vessel wall with an arc ≤90° with 
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acoustic shadowing. The frequency of thrombus, ruptured plaque, lipid pool-like image 
and spotty calcification was assessed visually. In VH-IVUS analysis, the volumetric 
reconstruction of the plaques was performed off-line using VH software (IVG3, 
Volcano Corp, Rancho Cordova, CA) using the trapezoidal method. For each segment, 
EEM and lumen borders were identified using automatic edge detection and manually 
corrected when necessary. Areas or volumes of the four different VH-IVUS plaque 
components were automatically calculated for every recorded frame and for the entire 
imaged segment. On the reconstructed color-coded tissue map, fibrous areas were 
marked in green, fibrofatty in yellow, dense calcium in white and necrotic core in red. 
The four VH-IVUS plaque components were reported in absolute amounts and as a 
percentage of plaque area or volume. 
On the other hand, thin-cap fibroatheroma (TCFA) is one type of vulnerable 
plaque morphology, and the rupture of TCFA with subsequent thrombus formation is 
accepted as the most frequent cause of ACS. The quantitative definition of TCFA by 
VH-IVUS (VH-IVUS defined TCFA; ID-TCFA) was plaque burden >50% and a 
confluent necrotic core extending >14 pixels along the circumference of the lumen on a 
400 × 400 pixel VH-IVUS image; the final assignment of the ID-TCFA phenotype 
required identification of ID-TCFA on 3 consecutive frames, with or without confluent 
dense calcium, by using an automated pixel detection algorithm based on a 
histopathologic classification system14. On the basis of this definition, we defined SNC, 
which represents the ruptured TCFA associated with deterioration of coronary flow 
during intervention, as a necrotic core foci with a maximum diameter of <14 pixels on a 
400 × 400 VH-IVUS image in the presence of >50% plaque burden except in the 
ID-TCFA frame (Fig. 1). SNC and ID-TCFA was analyzed using NIH ImageJ version 
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1.42q software (http://rsbweb.nih.gov/ij/) for the delineation and quantification of cross-
sectional areas of necrotic core foci in each frame. Subsequently, the proportion of SNC 
in the “all necrotic core area” and the total number of SNC at the minimum lumen area 
site were calculated, and the proportion of ID-TCFA, the total number of SCN, the 
maximum number of SNC, the proportion of SNC in the “all necrotic core volume”, and 
the average number of SNC/frame by dividing the total number of SNC by the total 
number of frames within the segment, were calculated. 
 
Statistical analysis 
Values are expressed as mean ± standard deviation or proportions. Differences 
between groups were analyzed by the Student’s unpaired t-test. Categorical data were 
compared by Chi-square analysis. Correlation was assessed by linear regression analysis 
and Pearson’s correlation coefficient. Univariate and multivariate logistic regression 
analyses were used to identify predictors of the deterioration of coronary flow during 
PCI procedure. Univariate predictors with P value <0.1 were entered into the 
multivariate model. A P value <0.05 was considered statistically significant. Stat View 
5.0 (SAS Institute, Cary, NC) was used for data analysis. 
 
Results 
A conventional wire was successfully positioned beyond the target lesions in all 
49 ACS patients. However, 11 cases had to be excluded from the analysis for the 
following reasons: the IVUS catheter could not be advanced beyond the calcified 
stenosis (3 cases); inadequate IVUS images (7 cases); and the wire dissection occurred 
before the IVUS catheter could be advanced beyond the stenosis (1 case). Therefore, 38 
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cases (30 males, 8 females; mean age 65.9 ± 13.6 years) were included in the final 
analysis. Patients were divided into a coronary flow deterioration group (n = 15) and a 
normal reflow group (n = 23) as determined by corrected TIMI frame count. 
Baseline characteristics, angiographical and PCI procedure analysis are listed in 
Table 1 and were not significantly different between the two groups with the exceptions 
of age (normal reflow group patients were significantly older than slow flow group 
patients) and post-interventional corrected TIMI frame count, which was statistically 
greater in the coronary flow deterioration group as befitted the classification. 
Conventional IVUS analysis is summarized in Table 2. The EEM CSA, plaque & media 
CSA and lumen CSA did not differ significantly at minimal lumen site. In contrast, the 
EEM volume was significantly greater in the coronary flow deterioration group than in 
the normal reflow group (P = 0.0292), but there was no statistical difference in the 
lumen volume (P = 0.39). Consequently, plaque & media volume was larger in the 
coronary flow deterioration group than in the normal reflow group (P = 0.0494). The 
presence of residual thrombus and ruptured plaque occurred more frequently in the 
coronary flow deterioration group than in the normal reflow group (P = 0.0096, P = 
0.0011, respectively). However, there were no differences between the two groups in 
the lipid pool-like image, positive remodeling and spotty calcification. 
We then analyzed plaque composition by VH-IVUS (Table 3). At the minimum 
lumen site, the absolute fibrous plaque area was significantly greater in the coronary 
flow deterioration group compared with normal flow group. Within the entire culprit 
lesions, the absolute fibrous volume was significantly greater in coronary flow 
deterioration group than in normal reflow group (P = 0.0318). Additionally, we 
investigated the VH-IVUS-derived plaque distribution analysis. At the minimum lumen 
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site, the number of SNC and the proportion of SNC/necrotic core were significantly 
greater in coronary flow deterioration group than normal flow group (P = 0.0004 and P 
= 0.0295, respectively). Within the entire culprit lesion, the incidence of ID-TCFA, the 
average number of SNC, and maximum number of SNC were significantly greater in 
coronary flow deterioration group than in normal reflow group. However, the 
proportion of SNC in the all NC volume did not differ between the two groups. 
Multiple logistic regression analysis between patients with and without 
deterioration of coronary flow, including age, EEM volume, absolute fibrous volume, 
residual thrombus, plaque rupture, the incidence of ID-TCFA, and the average number 
of SNC/frame as covariates, showed that the average number of SNC/frame (odds ratio 
1.182, 95% confidence interval 1.023 to 1.366, P = 0.0229) was the most effective 
predictor of coronary flow deterioration during PCI (Table 4). 
In order to evaluate the relationship between the severity of coronary flow 
deterioration and plaque distribution, a linear regression analysis was performed (Fig. 2). 
CTFC after mechanical dilation, which means the degree of deterioration of coronary 
flow during PCI, correlated strongly with the average number of SNC/frame (R = 0.71, 
P <0.0001), however, CTFC after mechanical dilation did not correlate with the 
incidence of ID-TCFA (R = 0.26, P = 0.1). 
We identified some ACS patients with coronary flow deterioration after 
intervention whose grayscale IVUS findings at the target lesion were a mixture of soft 
plaque and thrombi, and whose VH-IVUS findings from the target lesion showed SNC 
foci diffusely distributed throughout the plaque area, generally in plaque comprising 
mainly a mixture of fibrous and fibrofatty components, as shown in Fig. 3. Moreover, 
microscopic findings from materials collected by thrombectomy in some patients with 
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coronary flow deterioration with SNC by VH-IVUS were mixed thrombi and 
cholesterol clefts, which are considered as major causes of this phenomenon (Fig. 3). 
Fig. 4 shows VH-IVUS color-coded images and corrected TIMI frame count after 
mechanical dilatation from 3 representative cases. 
 
Discussion 
The present study demonstrated that the incidence of residual thrombus, plaque 
rupture, EEM volume, fibrous volume, the incidence of ID-TCFA, and the average 
number of SNC/frame were significantly greater in patients with coronary flow 
deterioration than in those with normal flow. Notably, in our ACS patients, the average 
number of SNC/frame was the most effective predictor of the occurrence of coronary 
flow deterioration during the intervention procedure, and there was a significant 
relationship between the average number of SNC within lesions on VH-IVUS and the 
degree of coronary flow deterioration. 
Recent VH-IVUS studies have demonstrated that, as a qualitative assessment, 
necrotic core component and necrotic core volume predict the risk of distal 
embolization after primary stent deployment in patients with ST-segment elevation 
myocardial infarction15. Bae et al. reported that fibrofatty volume was the only 
independent factor for slow flow during PCI in AMI patients16. In contrast to the 
previous studies, we found that fibrous volume was significantly greater in the coronary 
flow deterioration group than in the normal flow group. Therefore, the predictor of 
coronary flow deterioration by VH-IVUS in ACS patients remains controversial. 
Discrepancy between these findings might be explained by the existence of a thrombus 
at the analyzed lesions. In general, most patients with ACS are more likely to have 
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ruptured plaques with a superimposed thrombus at the target lesion17. The composition 
of thrombus tissue in ACS patients is very heterogeneous, because it depends on age of 
the thrombus18. Moreover, a thrombus cannot be identified using VH-IVUS because of 
a lack of histological validation. Nasu et al. reported that intramural thrombi were 
mistakenly colored as fibrous or fibrofatty tissue by VH-IVUS19. From the pathologic 
classification, an organized thrombus shows ingrown smooth muscle cells with or 
without depositions of connective tissue and capillary vessel growth, which is similar to 
fibrous plaque. Thus, because an organized thrombus could often have been included in 
the analysis area of VH-IVUS in this study, plaque composition of a target lesion 
obtained by VH-IVUS was in contradiction with histopathological data, with more 
fibrous tissue volume that could result in a lower percentage necrotic core volume in the 
coronary flow deterioration group compared with previous reports15, 20.  From these 
findings, it is possible that the difference between the various findings using VH-IVUS 
is a reflection of the presence of a thrombus and its relative age. Therefore, it is difficult 
to predict the deterioration of coronary flow during PCI in ACS by using the proportion 
of conventional 4 types of plaque tissue components obtained from VH-IVUS. 
In the present study, according to both VH-IVUS findings and pathological 
findings, we demonstrated that the identification of SNC by VH-IVUS would be 
associated with ruptured plaque with thrombus formation, which caused the 
deterioration of coronary flow. Furthermore, the most effective predictor of the 
deterioration of coronary flow was not fibrous volume but the average number of 
SNC/frame, which in turn may be influenced by the distribution of plaque components, 
rather than their relative proportions. On the other hand, a previous VH-IVUS study 
suggested that post-stenting no-reflow was associated with ID-TCFA in ACS patients20. 
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In the present study, although ID-TCFA was also observed more frequently in the 
coronary flow deterioration group than in the normal reflow group, the average number 
of SNC/frame was the most effective predictor of the occurrence of deterioration of 
coronary flow during the intervention procedure rather than the incidence of ID-TCFA. 
From these results, once vulnerable plaque is ruptured in ACS patients, it is difficult to 
detect ID-TCFA because intramural thrombi covered the necrotic core along the 
circumference of the lumen at the culprit lesion. Therefore, it is possible that the 
incidence of ID-TCFA in ACS may depend on the amount of residual intramural 
thrombus. However, the relationship between the presence of SNC and the occurrence 
of deterioration of coronary flow during the intervention procedure is still unclear. In 
humans, the no-reflow phenomenon has a multifactorial pathogenesis. Angioplasty-
induced distal coronary embolization of plaque and thrombus may compound the 
vascular obstruction. Furthermore an inflammatory response induced by neutrophils and 
platelets occurs at the time of reperfusion may exacerbate this process, which leads to 
further myocardial ischemia and cell death, resulting from a longer reperfusion time21, 22. 
As the necrotic core components contain fragile tissues, such as lipid deposition with 
foam cells, intramural bleeding, and cholesterol crystals, they can be easily liberated as 
small emboli by mechanical fragmentation during coronary stenting. Pathological 
analysis of the aspirates at the time of no-reflow phenomenon have detected not only 
thrombi but also plaque components including foam-shaped macrophages, aggregated 
platelets, and cholesterol crystals6, of which the latter might be identified by VH-IVUS 
as necrotic core. From these findings, SNC might be associated with the mixture of the 
thrombi and plaque component, such as cholesterol crystals. Moreover, the 
inflammatory response induced by aggregated platelets, which causes reperfusion injury, 
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may be associated with SNC. Further pathological studies are needed to clarify the 
relationship between SNC and the occurrence of coronary flow deterioration. 
 
Study limitations 
Some limitations of the study should be acknowledged. First, the accuracy of volumetric 
analysis by a motorized pull-back system Eagle EyeTM IVUS catheter may be lower 
than a mechanical rotational catheter23, because this motorized catheter pulls the IVUS 
catheter itself. However, in the present study, the IVUS catheter was pulled back 
smoothly, because most of the target lesion was soft after aspiration of the thrombus and 
plaque in patients with ACS, compared with tight and calcified stenosis in patients with 
stable angina pectoris. Therefore, we feel that the accuracy of volumetric analysis by an 
Eagle EyeTM IVUS catheter is acceptable to a certain extent in the clinical setting of 
ACS. Second, thrombus aspiration prior to IVUS was not performed for all patients, 
which may have biased the results. Third, as only 5 patients (13%) had final TIMI flow 
grade 2 or less (no-reflow group), it was difficult to compare no-reflow group with 
normal-reflow group in this study. No-reflow phenomenon has been reported to be 
predictive for poor clinical outcomes, whilst deterioration of coronary flow as defined in 
this study has not. Further studies are needed to clarify the relationship between 
deterioration of coronary flow and clinical outcomes. Fourth, this study is limited by the 
relatively small number of patients. However, SNC remained predictive of coronary 
flow deterioration during PCI despite the size of the patient sample. Larger studies will 





In addition to conventional indices such as EEM volume, increased SNC number 
by VH-IVUS is highly associated with corrected TIMI frame count after intervention. 
Approaches to preventing possible coronary flow deterioration in ACS patients who 
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Fig. 1.  An example of selective quantification of the scattered necrotic core 
(A) A conventional grayscale IVUS cross-sectional image at the target lesion. (B) 
Corresponding image using VH-IVUS. VH-IVUS shows plaque burden of 
84%, %fibrous (green) of 63%, %fibrofatty (light green) of 23%, %necrotic core (red) 
of 13% and %dense calcium (white) of 1%. (C) Each necrotic core area is selectively 
delineated. (D) Total number of necrotic core foci and each necrotic core area are 
automatically calculated by software. In this frame, the total number of necrotic cores is 
173 and the total number of scattered necrotic core is 90. 
 
Fig. 2.  Correlation between corrected TIMI frame count after mechanical dilation 
and plaque distribution 
Following mechanical dilation, there were significant correlations between corrected 
TIMI frame count and the average number of scatter necrotic core/frame (A), the 
incidence of VH-IVUS defined thin-cap fibroatheroma (ID-TCFA), however, did not 
correlate with corrected TIMI frame count after mechanical dilation (B).  
 
Fig. 3. Microscopic findings from materials collected by thrombectomy in a patient 
with deterioration of coronary flow 
(A) Microscopic findings from materials collected by thrombectomy in a patient with 
slow flow were mixed thrombi (left) and cholesterol clefts (right). (B) Images of 
grayscale IVUS (upper) and VH-IVUS (lower). Grayscale IVUS findings at the target 
lesion were a mixture of soft plaque and thrombi, and VH-IVUS findings from the 
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target lesion were a scattered necrotic core pattern generally in plaque comprising 
mainly a mixture of fibrous and fibrofatty components. 
 
Fig. 4.  Typical VH-IVUS images with or without coronary deterioration during 
PCI 
Typical VH-IVUS images without coronary deterioration (A and B) and with coronary 
deterioration during PCI (C). (A) The total number of scattered necrotic core is 10. (B) 
The total number of scattered necrotic core is 15. (C) The total number of scattered 





 Table 1. Baseline Characteristics 
 
 Coronary flow 
deterioration Group 
(n=15) 





Male 13 (86.7) 17 (73.9) 0.35 
Age (years) 59.9 ± 15.1 69.8 ± 11.2 0.0259 
Systolic BP (mmHg) 137.7 ± 22.4 134.7 ± 22.5 0.71 
Diastolic BP (mmHg) 71.8 ± 13.0 74.8 ± 13.3 0.55 
Heart rate (bpm) 77.3 ± 13.4 79.7 ± 13.3 0.64 
Ejection fraction (%) 47.0 ± 11.3 45.0 ± 8.4 0.57 
Systemic hypertension 7 (46.7) 15 (65.2) 0.26 
Diabetes mellitus 4 (26.7) 9 (39.1) 0.43 
Hypercholesterolemia 5 (33.3) 7 (30.4) 0.85 
Current smoker 6 (40.0) 4 (17.4) 0.11 
Diagnosis   0.19 
STEMI 11 (73.3) 10 (43.5)  
NSTEMI 1 (6.7) 4 (17.4)  
UAP 3 (20.0) 9 (39.1)  
Previous angina pectoris 2 (13.3) 4 (17.4) 0.74 
Previous MI 1 (6.7) 3 (13.0) 0.53 
Reperfusion time (h) 8.1 ± 5.2 6.0 ± 2.0 0.16 
Target coronary artery    
LAD/LCX/RCA 9/0/6 13/4/6 0.20 
Initial TIMI flow grade   0.20 
0/1/2 8/3/3 6/3/8  
3 1 6  
Pre-interventional QCA    
Lesion length (mm) 15.5 ± 7.7 14.8 ± 6.9 0.78 
Reference diameter (mm) 2.6 ± 0.6 2.3 ± 0.8 0.20 
Minimal lumen diameter (mm) 0.2 ± 0.4 0.3 ± 0.4 0.51 
Diameter stenosis (%) 91.3 ± 12.9 86.7 ± 16.0 0.36 
PCI procedure    
Direct stent 5 (33.3) 6 (26.1) 0.63 
POBA alone 3 (20.0) 1 (4.3) 0.12 
POBA + stent 7 (46.7) 16 (69.6) 0.16 
Max dilation pressure (atm) 14.9 ± 3.0 16.1 ± 3.2 0.25 
Final balloon or stent size (mm) 3.5 ± 0.7 3.3 ± 0.6 0.34 
Total stent length (mm) 21.2 ± 7.4 26.2 ± 12.6 0.23 
Balloon/artery ratio 1.4 ± 0.4 1.6 ± 0.6 0.27 
Post-interventional QCA    
Minimal lumen diameter (mm) 2.7 ± 0.6 2.4 ± 0.6 0.21 
Diameter stenosis (%) 10.4 ± 14.8 11.0 ± 10.0 0.88 
Final TIMI flow grade 3 10 (66.7) 23 (100) 0.003 
Corrected TIMI frame count after 
thrombectomy 
32.6 ± 18.3 38.1 ± 28.4 0.52 
Corrected TIMI frame count after 
mechanical dilation 
65.1 ± 56.2 20.3 ± 8.1 0.0006 
Data presented are mean values ± SD or a number (%) of patients. 
BP, blood pressure; LAD, left anterior descending; LCX, left circumflex; Max, maximum; MI, myocardial 
infarction; NSTEMI, non ST-segment elevation myocardial infarction; PCI, percutaneous coronary 
intervention; POBA, plain old balloon angioplasty; QCA, quantitative coronary angiography; RCA, right 
coronary artery; SD, standard deviation; STEMI, ST-segment elevation myocardial infarction; TIMI, 
Thrombolysis In Myocardial Infarction; UAP, unstable angina pectoris. 
 
Table 2. Conventional Intravascular Ultrasound Analysis 
 
 Coronary flow 
deterioration Group
 (n=15) 





Proximal reference    
EEM CSA (mm2) 20.2 ± 6.0 18.1 ± 6.3 0.32 
Lumen CSA (mm2) 8.0 ± 3.6 7.9 ± 4.0 0.91 
Plaque & media CSA (mm2) 11.4 ± 5.6 10.2 ± 3.5 0.43 
Minimal lumen site    
EEM CSA (mm2) 19.6 ± 8.4 16.0 ± 5.6 0.13 
Lumen CSA (mm2) 3.0 ± 0.5 3.1 ± 1.2 0.91 
Plaque & media CSA (mm2) 15.5 ± 9.0 12.9 ± 4.9 0.27 
 
Plaque burden (%) 82.2 ± 7.3 79.9 ± 6.0 0.32 
Remodeling index 1.0 ± 0.2 0.9 ± 0.2 0.30 
Positive remodeling (%) 5 (33.3) 6 (26.1) 0.63 
Distal reference    
EEM CSA (mm2) 14.4 ± 5.8 13.3 ± 5.6 0.57 
Lumen CSA (mm2) 7.0 ± 3.7 6.2 ± 3.4 0.56 
Plaque & media CSA (mm2) 7.4 ± 3.5 7.0 ± 3.4 0.73 
Volumetric analysis    
EEM volume (mm3) 162.2 ± 51.5 119.9 ± 55.2 0.0292 
Lumen volume (mm3) 39.8 ± 13.3 35.8 ± 13.3 0.39 
Plaque & media volume (mm3) 122.4 ± 49.8 91.5 ± 38.4 0.0494 
Qualitative analysis    
Residual thrombus 11 (73.3) 7 (30.4) 0.0096 
Plaque rupture 12 (80.0) 6 (26.1) 0.0011 
Lipid pool image 4 (26.7) 4 (17.4) 0.49 
Spotty calcification 11 (73.3) 13 (56.5) 0.29 
Data presented are mean values ± SD or a number (%) of patients. 
CS, cross sectional area; EEM, external elastic membrane. 
 
Table 3. Virtual Histology Intravascular Ultrasound Analysis 
 








Minimum lumen site    
Absolute plaque area (mm2)    
Fibrous 8.0±4.2 5.8±2.4 0.0478 
Fibrofatty 2.5±3.0 1.4 ±1.8 0.19 
Dense calcium 0.6±0.7 0.7±0.5 0.62 
Necrotic core 2.0±1.3 1.9±1.5 0.85 
Relative plaque area (%)    
Fibrous 61.1±12.0 59.0±13.4 0.64 
Fibrofatty 16.1±14.0 12.7±12.1 0.42 
Dense calcium 4.1±4.0 7.7±7.2 0.09 
Necrotic core 18.0±12.4 19.5±13.6 0.74 
Plaque distribution analysis    
SNC/necrotic core (%) 9.0±3.9 6.1±3.7 0.0295 
Number of SNC 71.5±42.8 33.3±16.8 0.0004 
Entire culprit lesion    
Absolute plaque volume (mm3)    
Fibrous 54.9±32.9 34.4±20.0 0.0318 
Fibrofatty 16.3±18.0 7.4 ±9.2 0.07 
Dense calcium 3.9±3.2 6.3±4.7 0.10 
Necrotic core 14.5±8.4 13.8±11.5 0.86 
Relative plaque volume (%)    
Fibrous 59.9±10.5 56.8±15.3 0.51 
Fibrofatty 15.9±13.6 11.1±8.5 0.22 
Dense calcium 6.5±5.6 10.1±7.7 0.12 
Necrotic core 17.9±10.4 22.1±12.4 0.31 
Plaque distribution analysis    
Thin-cap fibroatheroma (%) 42.5±37.1 14.1±24.2 0.0068 
Max number of SNC/lesion 76.1±42.4 42.6±25.0 0.004 
SNC/necrotic core (%) 7.5±3.2 6.6±3.8 0.48 
Average number of SNC/frame 42.3±32.1 12.4±7.7 0.0001 
Data presented are mean values ± SD. 
SNC, scattered necrotic core. 
Table 4.  Independent Predictors of Coronary Flow Deterioration by 
Multivariate Logistic Regression Analysis 
 Odds Ratio 95% CI p-value 
  Age (yrs) 0.96 0.87-1.06 0.430 
  Fibrous volume (mm3/cm) 1.03 0.96-1.10 0.458 
  EEM volume (mm3) 1.00 0.97-1.02 0.836 
  Residual thrombus (%) 1.64 0.17-15.86 0.667 
  Plaque rupture (%) 1.11 0.10-12.14 0.933 
Thin-cap fibroatheroma (%) 1.03 0.99-1.07 0.095 
  Number of SNC/frame 1.18 1.02-1.37 0.023 
CI: confidence interval; EEM: external elastic membrane; SNC: scattered necrotic core. 
